Valeant Pharmaceuticals International, Inc. named Joseph Papa as chairman and chief executive officer Monday, effective early May. Papa, who resigned as CEO of Perrigo Company plc Sunday, is taking over for CEO and director J. Michael Pearson. Papa has worked in the sector for more than 35 years, including 20 years of working with branded prescription drugs, the company said. Valeant shares were up 2.1% in pre-market trade.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
From:: Stock Market News